Nasdaq
NPCE
Neuropace, Inc.
- Health Care
- Listed 2021
- 1 day
- +1.5%
- 1 month
- −21.9%
- 1 year
- +56.4%
$13.90 · Mkt cap $474M
At the 6 Aug 2026 close
Nasdaq
Neuropace, Inc.
$13.90 · Mkt cap $474M
At the 6 Aug 2026 close
Neuropace, Inc. trades under the ticker NPCE on Nasdaq, in the Health Care sector (Medical/Dental Instruments). It has been listed since 2021. Its market capitalisation is $474M. The last closing price was $13.90, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +56.4%, and −21.9% over the past month. Returns are price returns and exclude dividends.
This page exists because NPCE is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.